Possible role of bacterial and viral infections in miscarriages by Matovina, Mihaela et al.
1 
 
Possible role of bacterial and viral infections in miscarriages 
 
Mihaela Matovina, M.Sc.
a
 
Koraljka Husnjak, M.Sc.
a
 
Nina Milutin, B.Sc.
 a
 
Srecko Ciglar, M.D., Ph.D.
b
 
Magdalena Grce, Ph.D.
a
 
 
“Rudjer Boskovic” Insitute, Division of Molecular Medicine, Bijenicka cesta 54, HR-10002 
Zagreb, Croatia 
 
Received April 9, 2003; revised ... and accepted ... 
Supported by grants (number: 044001 and 098104) from Croatian Ministry of 
Science and Technology, Zagreb, Croatia. 
Reprint requests: Magdalena Grce, Ph.D., “Rudjer Boskovic” Institute, 
Bijenicka cesta 54, HR-10002 Zagreb, Croatia. 
(FAX: +38514561010; e-mail: grce@irb.hr). 
a
 Rudjer Boskovic” Insitute, Division of Molecular Medicine, Bijenicka cesta 
54, HR-10002 Zagreb, Croatia. 
b University Hospital “Merkur”, Departmant of Obstetrics and Gynecology, 
Zajceva 19, HR-10000 Zagreb, Croatia. 
 
 
 
 
 
 
Capsule 
 
With the use of polymerase chain reaction, human papillomavirus and Chlamydia trachomatis 
were detected in 7.4 % and 1 % of placental samples from miscarriages, respectively. 
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Structured abstract and key words 
 
Objective: In order to determine the role of infections in miscarriages, chorionic villi from 
aborted material were subjected to cytogenetic evaluation and analysed for the presence of 
Chlamydia trachomatis, Ureaplasma urealyticum, Mycoplasma hominis, human 
cytomegalovirus (HCMV), adeno-associated virus (AAV) and human papillomaviruses 
(HPV). 
Design: Retrospective study. 
Setting: University hospital and academic research institution.  
Main Outcome Measure(s): Karyotyping and detection of bacterial and viral DNA by means 
of polymerase chain reaction (PCR) in placenta specimens. 
Result(s): In 54 (50 %) of 108 samples the karyotype was normal, in 38 (35 %) samples it 
was abnormal and in 16 (15 %) samples karyotype was undetermined. No U. urealyticum, M. 
hominis, HCMV or AAV 2 DNA was detected, while C. trachomatis DNA was detected in 
one (1 %) and HPV DNA in eight (7 %) samples. No significant correlation of HPV positive 
findings with karyotype status was established. 
Conclusion(s): Our findings do not support a role of C. trachomatis, U. urealyticum, M. 
hominis, HCMV and AAV infections in miscarriages during the first trimester of pregnancy. 
However, further investigation should be made to determine a possible involvement of HPVs 
in the development of genetic abnormalities of the fetus, and in miscarriages. 
Key Words: Miscarriage, karyotyping, placenta, PCR, bacterial infections, viral infections 
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INTRODUCTION 
Miscarriages are considered to be the most common complication in pregnancy. The 
incidence of miscarriages in clinically established pregnancies (over sixth gestational week) is 
approximately 12 to 15 % (1). Recurrent (three or more consecutive) miscarriages represent a 
special problem resulting with serious physical as well as psychological damage to women. 
Unfortunately, they occur quite often, in 1 out of 300 pregnancies (2). 
Several possible causes of miscarriage have been considered, the major ones being 
genetic abnormalities of the fetus. It has been established that more than 50 % of miscarried 
fetuses are genetically abnormal (3, 4). Apart from that, other causes of miscarriage could be 
anatomical anomalies of the mother, endocrine and immunological causes, different 
environmental factors, such as exposure to various toxic substances (caffeine, nicotine), and 
infections (5-7). According to Garcia-Enguinados et al. (8), only genetic and anatomical 
abnormalities have been proven as direct causes of miscarriages, whereas intrauterine 
infections have been established as a cause of premature rupture of fetal membranes and 
preterm labor, and their role in miscarriage is still not completely clear. Several studies have 
confirmed the role of infections as a cause of miscarriage, especially during the second 
trimester of pregnancy, but the role of infection in first trimester miscarriages is still 
questionable (9). 
Since the main route of infection to placenta and fetus is from vagina and cervix, most 
studies were oriented on an attempt to find an association between miscarriage and abnormal 
bacterial flora in the lower genital tract, vagina and cervix, respectively. Gardnerella vaginalis 
and Mycoplasma hominis both cause vaginitis and are often found in mixed infections as a 
cause of amnionitis, whereas Ureaplasma urealyticum is found as a sole cause of amnionitis 
(10, 11). These pathogens are also considered as a cause of preterm labor, beside Escherichia 
coli, enterococci, staphylococci and group B streptococci (12).  
A microorganism should have access to the intrauterine surroundings in order to cause 
inflammatory reaction of endometrium or fetal tissues responsible for a miscarriage. 
Infectious agents present inside the uterus can cause infections between decidual tissue and 
fetal membranes (amnion and chorion), inside placenta, in the amniotic fluid (amnionitis) or 
in the umbillical cord (funisitis). Infections of the placenta are rare and the most common 
causative agents found are Treponema pallidum, Mycobacterium tuberculosis, chlamydias, 
mycoplasmas, Rubella virus, human cytomegalovirus (HCMV), herpes simplex virus (HSV), 
Toxoplasma gondii and Candida albicans (13, 14). However, it has not been established 
whether such infections cause miscarriage. 
Witkin et al. (15) established that Chlamydia trachomatis could provoke miscarriage 
due to strong immunological reaction to the specific bacterial protein. Moreover, C. 
trachomatis infections of the cervix have been associated with second trimester abortions and 
premature membrane rupture (16).  
It is well established that mycoplasmas are prevalent in the lower genital tract of 
pregnant women, but they are also quite common in the genitourinary tract of sexually active 
men and women in general (17). Some studies suggest an association of mycoplasma infection 
with sporadic and recurrent miscarriages (18, 19).  
HCMV is the most common congenital infection in humans, with the incidence of 1 % 
of all live births (20). However, there is no consensus about HCMV involvement in 
spontaneous abortions (21, 22).  
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Adeno-associated virus (AAV), which is not a priori associated with diseases in 
humans (23), has been found in human blood cells, biopsies and cervical epithelial cell 
brushings, endometrium and material from spontaneous abortion which indicates its possible 
role in miscarriage induction (24-27).  
The role of HPV in the development of cervical carcinoma is well-established (28), 
however its involvement in the development of miscarriage is also under consideration (29, 
30).  
Herein, we investigated the association of first trimester miscarriages with the 
placental presence of suspected pathogens involved in the induction of miscarriages, i.e. U. 
urealyticum, M. hominis, C. trachomatis, HCMV, AAV and HPV. 
 
MATERIAL AND METHODS 
Patients 
Hundred and eight Croatian women attending the Clinic of Gynecology and Obstetrics 
in University Hospital “Merkur” (Zagreb, Croatia) were involved in this study. Each woman 
was admitted to the hospital because of the threatening miscarriage. All of them were 
informed about the following therapeutic and diagnostic procedures and agreed by signed 
consent. They were 18 to 46 years old (mean age 32 years), and the gestational age at which 
miscarriage occurred was between 4 and 19 weeks (mean gestational age 10 weeks). Their 
uterine cervices were normal and chronic or hereditary diseases were excluded.  
The Ethical Board of the University Hospital “Merkur” and the Ethical Board of the 
“Rudjer Boskovic” Institute approved further analysis presented in this study.  
Tissue sampling 
Placental tissue was collected by curettage, cleaned of decidual tissue, rinsed in 
HAMS F10 medium (Gibco BRL) and dissected under a stereoscopic microscope. Chorionic 
villi were used to determine the karyotype of the fetuses and DNA was isolated from the 
placental tissue in order to investigate the presence of bacterial and viral infections by means 
of polymerase chain reaction (PCR). Karyotyping was performed at the Laboratory for 
cytology and clinical genetics, University Hospital “Merkur” (Zagreb, Croatia) while the 
molecular analyses were performed at the Laboratory of Molecular Oncology, Division of 
Molecular Medicine, “Rudjer Boskovic” Institute (Zagreb, Croatia).  
Cytogenetic analysis 
The direct method for karyotyping chorionic villi was performed according to Singer 
and Profeta (31). Briefly, chorionic villi were cultivated for 1 to 3 days at 37°C. An hour and 
30 minutes before proceeding with slide preparations, 0.01 mg/ml of Colchicine (Fluka) was 
added to the medium to stop the cells in the metaphase of mitosis. The tissue was then 
removed from the medium and treated with hypotonic and fixative solution (3:1 methanol and 
acetic acid) in order to preserve cells in their "swollen" state. After the removal of fixative, a 
few drops of 60 % acetic acid were added to the tissue to cause cell dissociation. One drop of 
the cell suspension was placed on each slide and spread across it. The chromosomes were Q- 
and G-banded, which enabled their identification and analysis. Fifteen metaphases of each 
sample were analysed under the microscope and at least three metaphases were photographed 
and subjected to further analysis in order to determine the chromosome number, the structural 
chromosomal abnormalities and, finally, the karyotype.  
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DNA isolation 
The placenta samples were resuspended in lysis buffer (10 mM Tris-HCl, pH 7.5, 1 
mM EDTA, pH 7.9, 0.5 % SDS) and treated overnight at 37°C with proteinase K (100 g/ml). 
The DNA was isolated by a phenol and chloroform extraction followed by ethanol 
precipitation, and dissolved in tridistillated sterile water, according to Sambrook et al. (32).  
Polymerase chain reaction (PCR) 
Each DNA sample was subjected to several PCR reactions in order to amplify DNA of 
U. urealyticum, M. hominis, C. trachomatis, HCMV, AAV 2 and HPVs. Prior to PCR analysis 
of DNA samples for the presence of different microorganisms, primer set PC04/GH20 was 
used to amplify part of the -globin gene in order to exclude possible presence of inhibitors of 
the PCR and to optimise sample DNA concentration (33).  
The detection of U. urealyticum and M. hominis was done by semi-nested PCR 
according to Abele-Horn et al. (34). Primer pairs U4/U5 and U4/U9 (Table 1) were used to 
amplify part of the U. urealyticum urease gene, while primer pairs M1/M2 and RNAH3/M2, 
complementary to the part of M. hominis rrn B operon of the 16S rRNA gene (Table 1), were 
used for the detection of M. hominis. The reaction mixture (20 l) consisted of 10 mM Tris-
HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 0.1 mM of each dNTP, 0.5 M of each primer, 
approximately 100 ng of each DNA and 0.4 U of a thermostable AmpliTaq DNA polymerase 
(Roche). PCR reactions were performed for 40 cycles of denaturation (95 C, 30 s), annealing 
(46 C, 30 s for U. urealyticum; 45 C, 30 s for M. hominis) and elongation (72 C, 45 s). DNA 
extracted from cultured U. urealyticum and M. hominis (kindly provided by Dr. Z. Persic, 
Zagreb, Croatia) was used as positive control. 
Detection of C. trachomatis was done according to Loeffelholz et al. (35). Primer pair 
CP24/CP27 (Table 1) was used to amplify part of C. trachomatis cryptic plasmid. The 
reaction mixture (20 l) consisted of 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 
0.1 mM of each dNTP, 0.5 M of each primer, approximately 100 ng of each DNA and 0.4 U 
of a thermostable AmpliTaq DNA polymerase (Roche). PCR reaction was performed for 35 
cycles of denaturation (95 C, 50 s), annealing (62 C, 35 s) and elongation (72 C, 35 s). DNA 
extracted from C. trachomatis (ATCC number: VR-878) was used as positive control. 
Two sets of primers, complementary to the early regulatory region of HCMV genome 
(IEA1 gene) CMV-C/ CMV-D and CMV-A/ CMV-B (Table 1) were used in a nested PCR 
(36). The reaction mixture (20 l) consisted of 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 
mM MgCl2, 0.25 M of each dNTP, 0.15 M of primers CMV-C and CMV-D in the first 
reaction and 0.6 M of primers CMV-A and CMV-B in the second reaction, approximately 
100 ng of each DNA and 0.4 U of a thermostable AmpliTaq DNA polymerase (Roche). The 
first round of PCR with the primer pair CMV-C/ CMV -D was performed for 20 cycles, while 
the second round of PCR with the primer pair CMV -C/ CMV -D was performed for 30 cycles 
of denaturation (95 C, 30 s), annealing (53 C, 30 s) and elongation (72 C, 45 s). DNA 
extracted from Wi-38 (ATCC number: CCL-75) cells infected with HCMV (ATCC number: 
VR-807) was used as positive control.  
AAV 2 was detected in a semi-nested PCR. Two sets of primers R78-1/nest2 and R78-
1/R78-2 (Table 1) (37, 38), complementary to the regulatory region of AAV genome (REP 
gene), were used. The reaction mixture (20 l) consisted of 10 mM Tris-HCl (pH 8.3), 50 mM 
KCl, 1.5 mM MgCl2, 0.2 M of each dNTP, 0.2 M of each primer, approximately 100 ng of 
each DNA and 0.4 U of a thermostable AmpliTaq DNA polymerase (Roche). The first and 
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second round of PCR were performed for 30 cycles of denaturation (95 C, 30 s), annealing 
(63 C, 30 s) and elongation (72 C, 45 s). Cloned AAV 2 DNA (kindly provided by Dr. J. R. 
Schlehofer, Heidelberg, Germany) was used as positive control. 
PCR conditions for HPV DNA amplification were as previously described (39). 
Briefly, for HPV screening MY09/MY11 (40) primers were used, while for HPV typing, type-
specific primers for HPV 16 and HPV 18 (41) were used (Table 1). DNA isolated from CaSki 
(ATCC number: CRL-1550) and HeLa cells (ATCC number: CCL-2), which contain 
integrated HPV 16 and HPV 18 DNA, respectively, were used as positive controls. 
Amplified products were resolved by electrophoresis in a 2% agarose gel stained with 
ethidium bromide, identified by UV irradiation and photographed (ImageMaster, Pharmacia 
Biotech). 
 
RESULTS 
The majority of the miscarriages, 102 of 108 (94.4 %) occurred during the first 
trimester of pregnancy, whereas only 6 (5.6 %) occurred in the second trimester. Fifty-five 
(50.9 %) women miscarried for the first time, 27 (25 %) had one previous miscarriage and 26 
(24.1 %) had two or more previous miscarriages, of which only 12 (46.2 %) had more than 
two consecutive miscarriages, so they can be classified as having recurrent miscarriages 
(Figure 1).  
According to cytogenetic analysis in 16 (14.8 %) of 108 samples karyotype could not 
be determined due to culture failure (insufficient cell growth in 15 cases and one case 
ofexogenous contamination ). In the remaining 92 samples, 54 (50 %) had normal karyotype 
and 38 (35.2 %) had abnormal karyotype. The most frequently found chromosomal 
abnormalities were autosomal trisomies in 27 (71 %) of 38 cases (Table 2). One (3 %) 
monosomy 21 (karyotype 45,XY,-21), two (5 %) cases of monosomy X, three (8 %) 
triploidies, three (8 %) tetraploidies and two (5 %) mosaicisms were also found (Table 2). 
Each DNA sample isolated from placenta of miscarried fetuses was -globin positive 
and thus suitable for further analysis, i.e. detection of U. urealyticum, M. hominis, C. 
trachomatis, HCMV, AAV 2 and HPVs by PCR. The results of bacterial and viral DNA 
detection, by means of PCR, are summarised in Table 3. 
To detect the presence of U. urealyticum and M. hominis, a semi-nested PCR instead 
of one step PCR was performed in order to increase sensitivity and specificity of the reaction. 
However, the presence of either bacterium was not detected in any analysed sample.  
The presence of C. trachomatis was established in only one (1.0 %) of 108 samples 
(Table 3). The sample, in which C. trachomatis was detected, had normal karyotype and 
belonged to a patient without previous miscarriages or births, who was impregnated through 
in vitro fertilization (IVF). 
In order to investigate the presence of HCMV and AAV 2, nested and semi-nested 
PCR were performed. None of the samples contained either virus.  
Although no HPV DNA was detected by consensus MY09/MY11 primers, 8 (7.4 %) 
of 108 samples were positive with type-specific primers for HPV 16 and HPV 18. Two 
samples were positive for HPV 16 and HPV 18, respectively, while 4 samples were positive 
for both HPV types (Table 3). 
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All HPV positive samples were from women who had miscarriages in the first 
trimester of pregnancy, 5 of them had 2 or more previous miscarriages, one had 1 previous 
miscarriage and 2 did not have any previous miscarriages (Table 4). Those with no previous 
miscarriages were impregnated through IVF procedures. Three of the samples infected with 
HPV had abnormal, 3 had normal and in 2 cases the karyotype was undetermined. 
 
DISCUSSION 
Although miscarriage represents the most common complication in pregnancy and as 
such has been thoroughly investigated, the causes of miscarriages are still unexplained in the 
majority of cases. There are several indications connected to miscarriage, but only genetic and 
anatomical abnormalities are mostly accepted. Uterine infections are not generally accepted as 
a cause of miscarriage, since the results of different studies are inconsistent.  
There are contradictory results regarding an association of pathogens with the 
incidence of miscarriage. A number of studies attempted to find a possible connection 
between miscarriage and bacterial infections in the vagina, with the assumption that such 
infections could spread to uterus and induce miscarriage. Robertson et al. (42) found a 
connection between colonisation of vagina with U. urealyticum and premature labor, and 
Donders et al. (7) found that bacterial vaginosis and presence of U. urealyticum and M. 
hominis in the vagina were associated with an increased risk of early miscarriage. U. 
urealyticum has also been found in the placenta, associated to perinatal morbidity and 
mortality and preterm labor (43, 44). However, colonisation of the uterine cervix with U. 
urealyticum is quite common in women who did not experience any problem during 
pregnancy (45), so its possible role in induction of miscarriage is questionable.  
According to our previous study of 53 pregnant women, U. urealyticum was present in 
the cervices of 20 (38 %) of 53 women, while M. hominis was not detected in any of samples 
(unpublished data). Furthermore, we also investigated the presence of mycoplasmas in the 
cervix among 18 women with previous miscarriage, and only U. urealyticum was found in 5 
(28 %) women (unpublished data). These observations do not favour the hypothesis that 
colonisation of cervix with mycoplasmas could be associated with miscarriages. Furthermore, 
we did not detect either the presence of U. urealyticum nor M. hominis in any of 108 samples 
of the placenta from miscarried fetuses that were analysed herein. There is no doubt in 
accuracy of these findings, since PCR is a highly sensitive and specific method and it is highly 
unlikely that an infection remained undetected. Moreover, we amplified the β-globin gene in 
all the samples, so the presence of inhibitors of PCR in the samples was also excluded.  
C. trachomatis and N. gonorrhoeae are the most frequent cause of cervicitis. They can 
ascend to the uterus and ovaries and possibly by vertical transmission to placenta and fetus 
(46). Indications of involvement of C. trachomatis in the development of miscarriage do exist, 
however there is not enough evidence to confirm them. Stokes and Isada (47) established that 
C. trachomatis infects placental trophoblast membrane cells in vitro. Study conducted among 
women undergoing the procedure of IVF implicated a connection between the presence of C. 
trachomatis in cervical scrapings and the failure of implantation and adverse pregnancy 
outcome (48). In our study we detected C. trachomatis in the placenta of a woman that 
miscarried after IVF, which is concordant with the fact that C. trachomatis could infect 
placental cells in vivo. Since, only 1 (1.0 %) of 108 miscarried placenta was positive for C. 
trachomatis, we cannot assume that C. trachomatis plays a significant role in the induction of 
most miscarriages.  
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Viral infections of the trophoblast, even with viruses that have little or no 
pathogenicity, are also considered as possible causes of miscarriage, since they can impair 
trophoblast function and lead to abnormal implantation and placentation (49). For instance, 
HCMV is the most common congenital infection in humans. Primary infections with HCMV 
occur in 0.7 to 4.1% pregnancies (50), however, whether they have a role in the induction of 
miscarriage is questionable. Van Lijnschoten et al. (51) emphasize the possibility of HCMV 
transplacental transfer – they found the presence of pp65, protein of HCMV, in trophoblastic 
cells in 6.7% (6/89) cases of spontaneous and induced abortions, but they did not demonstrate 
that the presence of HCMV is pathogenic for early pregnancy. Transplacental transfer was 
also confirmed in a mouse model by Li and Tsutsui (52). Fisher et al. (53) showed that 
HCMV infects placental trophoblasts and diminishes their normal function, which could lead 
to miscarriage. However, herein, we did not detect HCMV DNA in any of the samples, and 
our results do not support the hypothesis that HCMV might play a role in the induction of 
miscarriage.  
AAVs are human helper virus-dependent parvoviruses, which require helper viruses 
for their replication. Adenoviruses, herpes viruses, vaccinia virus and HPVs
 
have been 
identified as helper viruses for AAV (26, 54). According to several studies AAV DNA has 
been detected in placental tissue of human origin (25, 27). The virus is widespread in the 
population, but without any obvious pathogenic effect (55). AAV 2 is the most frequent AAV 
type infecting the human population (38). Botquin et al. (56) established that infection of 
pregnant mice with AAV 2 induced fetal death and early abortion. Kiehl et al. (57) detected 
AAV DNA in 11 (73 %) of 15 samples from spontaneous abortion. However, they did not 
detect HCMV in any of the samples, while HPV was detected in only one sample of 
spontaneous abortion. On the other hand, Friedman-Einat et al. (58) analysed a number of 
clinical samples of different origin, among which 62 samples were from first trimester 
abortions (38 spontaneous and 24 induced abortions). They did not find AAV DNA in any of 
aborted material samples, although they found the presence of AAV DNA in 18 % of genital 
swab samples. Our findings are in concordance with results of the Friedman-Einat et al. study 
(58), as we did not detect AAV DNA in any placentas from spontaneously aborted fetuses. 
Because there is a large discordance in different studies performed so far, further 
investigations are required. One possible explanation for such discrepancies in detection of 
AAV in cervical scrapings could be different prevalence of AAV infection in different 
populations, which was proposed by Venturoli et al. (59).  
An increase of HPV during pregnancy has been observed (60) and its transplacental transfer 
has been proposed by some authors (61), but also disputed by others (62). However, Hermonat 
et al. (29) found that HPV prevalence in placentas from first trimester miscarriages was as 
high as 60 % compared to 20 % prevalence in electively aborted fetuses. In their 1998 study, 
conducted on the subset of paraffin-embedded tissue from their previous study, Hermonat et 
al. (30)
 
determined that the preferential site of HPV infection was syncytiotrophoblast and 
since trophoblasts maintain placental contact with maternal tissue, they assumed that altered 
characteristics of HPV-infected trophoblasts might lead to miscarriage. The results of the Liu 
et al. (63) study showed that HPV16 carries out its complete life cycle in cultured placental 
trophoblasts, which is in concordance with the aforementioned study. Contrary to that in the 
Sifakis et al. (64) study no HPV DNA was detected in spontaneously aborted material. 
Malhomme et al. (27) examined 26 paraffin sections from uterine biopsies and early 
misscarriage that contained AAV for the presence of AAV helper viruses adenovirus, HSV 
and HCMV. They did not find the presence of these viruses in any of the samples, but they did 
find HPV DNA in 60 % samples from uterine biopsies and approximately 70 % of early 
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miscarriage samples. Armbruster-Moraes et al. (65) also detected HPV in 64.9 % (24/37) of 
amniotic fluid samples taken from pregnant women with cervical lesions indicative for HPV 
infection. Furthermore, Eppel et al. (66) conducted a study of HPV infection on chorionic villi 
and placental biopsies taken for the purpose of genetic analysis after the twentieth week of 
pregnancy. They found 24.6 % (44/179) HPV infection rate in the cervices of women, but did 
not find HPV in any of 147 placentas and chorionic villi examined. The difference in 
detection of HPV in the aborted tissue found in different studies is very puzzling, as it varies 
from 0 to 70 %.  
Herein, we found the presence of HPV DNA in 7.4 % of miscarriage specimens, 
which does not point toward a major role of HPV infection in the induction of miscarriages, 
but it confirms the possibility of its transplacental transfer. Also, since the infection was found 
in three samples that had abnormal karyotype and additional two samples with undetermined 
karyotype, further investigations of a possible association between HPV infection and 
development of genetic abnormalities during embryogenesis would be in order, at least on 
animal model, since it is established that HPV is the cause of genetic instabilities which result 
with the development of various types of complex chromosomal abnormalities in malignant 
tumor cells (28). It should also be noted that, by using consensus primers (MY09/MY11), 
which recognise L1 region of HPV genome, we did not detect HPV in any of placental 
samples, although by using type-specific primers for HPV 16 and HPV 18, HPV infection was 
detected in 8 samples. This could be due to greater sensitivity of type-specific primers, in case 
of low copy number of viral genome in the analyzed material
 
(39). Another explanation could 
be that HPV 16 and HPV 18, which are frequently integrated in the genome of cervical cells, 
are also integrated into the cell genome of placental cells (not investigated herein), and as such 
could be involved in the development of genetic abnormalities of the placenta and/or the fetus. 
Our results show that the number of HPV positive samples is proportionally higher in the 
group of women with two or more previous miscarriages, but it is not possible to conduct 
statistical analysis due to small number of samples and low expectancy values.  
The possibility of sample contamination with cervical cells is not excluded, since the 
samples were acquired during curettage and they passed through cervix and vagina. However, 
in that case we would expect to detect other pathogens that are common inhabitants of the 
cervix and vagina, i.e. C. trachomatis (detected only in 1 sample herein), U. urealyticum and 
M. hominis (not detected herein). In this study, only one placental sample was contaminated 
by exogenous infection during cell cultivation for karyotyping, which can be the consequence 
of contamination with pathogens commonly found in the surroundings. So, the fact that we 
did not detect other pathogens by PCR, points to the conclusion that the HPV positive 
findings in the placenta are not the consequence of the contamination during the passage 
through cervical canal, but indeed HPV infection of the placenta. 
Although the results of our study do not confirm a role of C. trachomatis, U. 
urealyticum, M. hominis, HCMV and AAV infections as a cause of miscarriages in the first 
trimester of pregnancy, the role of additional infections could not be excluded. Thus HPV 
infections, found herein in 7.4 % cases, necessitate further investigation. 
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Table 1 List of oligonucleotides used in this study 
Microorganism Primer 5’-3’ Size (bp) References 
M. hominis 
M1 CAA TGG CTA ATG CCG GAT ACG C 
M1/M2: 335 
M2/RNAH3: 284 
Abele-Horn et al. (34) M2 GGT ACC TGC AGT CTG CAA T 
RNAH3 CGC TGT AAG GCG CAC RAA A 
U. urealyticum 
U4 ACG ACG TCC ATA AGC AAC T 
U4/U5: 430  
U4/U9: 258 
Abele-Horn et al.
 
(34) U5 CAA TCT GCT CGT GAA GTA TTA C 
U9 GAG ATA ATG ATT ATA TGT CAG GAT CA 
C. trachomatis 
CP24 GGGATTCCTGTAACAACAAGTCAGG 
207 
Loeffelholz et al. (35) 
CP27 CCTCTTCCCCAGAACAATAAGAACAC 
HCMV 
C TGAGGATAAGCGGGAGATGT 
242 
Brytting et al. 
 (36) 
D ACTGAGGCAAGTTCTGCAGT 
A AGCTGCATGATGTGAGCAAG 
146 
B GAAGGCTGAGTTCTTGGTAA 
AAV 2 
NEST2 AGT TCA AAT TTG AAC ATC CGG TC 
R78-1/NEST2: 324  
R78-1/R78/2: 221 
Han et al. (37) 
Tobiasch et al. (38) 
R78-1 CAT CGC GGA GGC CAT AGC CC 
R78-2 ACG GGA GTC GGG TCT ATC TG 
HPV 
MY11 GCM CAG GGW CAT AAY AAT GG * 
450 Manos et al. (40) 
MY09 CGT CCM ARR GGA WAC TGA TC * 
HPV 16-F CCC AGC TGT AAT CAT GCA TGG AGA 
253 
Soler et al. (41) 
HPV 16-R GTG TGC CCA TTA ACA GGT CTT CCA 
HPV 18-F CGA CAG GAA CGA CTC CAA CGA 
201 
HPV 18-R GCT GGT AAA TGT TGA TGA TTA ACT 
* M=A+C, R=A+G, W=A+T, Y=C+T 
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Table 2 Types of genetic abnormalities found in the study group (N=38) 
 
Type of abnormality 
Chromosomes 
involved / karyotype 
Number of 
cases 
Trisomy 
2 1 
4 2 
5 2 
7 1 
8 1 
9 4 
13 2 
15 1 
16 3 
17 1 
18 1 
21 4 
22 4 
Monosomy 21 21 1 
Monosomy X X 2 
Triploidy whole set 3 
Tetraploidy whole set 3 
Mosaicism 
46,XX/92XXXX 1 
46,XX/69,XXY 1 
 
 
Table 3 The presence of bacterial or viral DNA in aborted placental tissue (N=108) 
 
Microorganism 
Normal karyotype Abnormal karyotype 
Undetermined 
karyotype 
positive  negative  positive  negative  positive  negative  
U. urealyticum 0 54 0 38 0 16 
M. hominis 0 54 0 38 0 16 
C. trachomatis 1 53 0 38 0 16 
AAV 2 0 54 0 38 0 16 
HCMV 0 54 0 38 0 16 
HPV 3 51 3 35 2 14 
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Table 4 Samples positive for the presence of high risk HPV DNA 
 
Sample Age 
Gestational 
week Karyotype 
Number of live 
births 
Number of 
miscarriages Comments HPV16 HPV18 
1 26 7 46,XX 3 2  - + 
2 36 10 46,XX 1 2  + + 
3 32 9 ND * 1 4  + + 
4 25 10 92,XXYY 0 2  + + 
5 25 5 46,XX 0 0 IVF † + + 
6 30 8 ND * 1 2 CIN III ‡ - + 
7 35 8 47,XY,+22 0 1  + - 
8 35 10 47,XY,+9 1 0 IVF † + - 
* ND, not determined; † IVF, in vitro fertilisation; ‡ CIN III, cervical intraepithelial neoplasia grade III 
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Figure 1 Number of previous miscarriages in the study population (N108) 
0  no previous miscarriages; 1  one previous miscarriage; 2  two or more previous miscarriages 
